Fundz

Triomics

SAN FRANCISCO, California, United States · Information Technology

Triomics combines the most advanced clinical trial tracking software with a global network of supersites and partners to deliver rapid, cost-effective, high quality clinical trials that pass even the most rigorous regulatory scrutiny.

Key facts

Headquarters
SAN FRANCISCO, California, United States
Employees
Unknown
Industries
Information Technology
Status
Private
Website
triomics.in
LinkedIn
Company page

Recent activity at Triomics

Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.

Triomics funding history

DateRoundAmount
May 2026Series B$22.0M
Dec 2022Venture$13.8M

Leadership

  • Sarim Triomics, Co-founder & CEO
  • Daniel, Medical Director; Founding Marketer
  • Harsh Jain, Director of Market Intelligence
  • Sameer Brij Verma, Director
  • Devtosh Kumar Khare, Director
  • Hrituraj Singh, Director
  • Sajjan Rajpurohit, Director
  • Sarim Khan, Executive Officer, Director

Verified email and direct lines for Triomics’s decision-makers are on Fundz. See plans or book a 15-minute walkthrough.

Employee benefit plans

Triomics files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.

Triomics in the news

Companies similar to Triomics

About Triomics: questions and answers

What does Triomics do?

Triomics combines the most advanced clinical trial tracking software with a global network of supersites and partners to deliver rapid, cost-effective, high quality clinical trials that pass even the most rigorous regulatory scrutiny.

Where is Triomics headquartered?

Triomics is headquartered in SAN FRANCISCO, California, United States.

Has Triomics raised funding?

Yes. Fundz has recorded 2 funding events for Triomics. The most recent, Series B of $22.0M, was in May 2026.

Who leads Triomics?

Sarim Triomics is a Co-founder & CEO at Triomics.

What is the latest news on Triomics?

On May 27, 2026, Triomics raises $22M in Series B funding led by Battery Ventures to enhance its oncology-specific AI platform.

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches Triomics across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.